Skip to content
Home/Companies/MedTech/Stago
ST

Stago

MedTech·France·Active·0yr hold
Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Stago?

Stago is currently owned by ARCHIMED through MED I (2014 vintage), since 2026.

Hand-verified · updated 2026-05-07

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

StatusActive

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
Fytexia
Exited 2023
HealthTechFrance· 2016
to
Micromed
Exited 2023
MedTechFrance· 2016
to
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings